In less than 36 hours between the evening of Jan. 12 and the morning of Jan. 14, three local life science companies raised a ...

So far this month, Tune Therapeutics, which has dual headquarters in Seattle and Durham, North Carolina, and Bellevue-based health care tech company Truveta have raised rounds of $175 million and ...

After hours: January 24 at 4:00:09 PM EST Loading Chart for ABEO ...

After hours: January 27 at 5:11:25 PM EST Loading Chart for ALDX ...

Vast Therapeutics is celebrating the new year with Series A funding in excess of $15 million from Shionogi & Co., Ltd. (TYO: 4507) of Japan and a $300,000 award from the Cystic Fibrosis Foundation.

Sanofi S.A. Part Cert 0.06% €8.19M ...

You’ve certainly heard about antibodies, peptides, and even DNA as therapeutics, but what about RNA? In this review, we take a look at what’s happening in a field that some believe may be as big a ...

“It’s not an easy life, but it is challenging and rewarding to be a part of this industry.” Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 ...

North Carolina-based biotech Tune Therapeutics has raised $175 million in a Series B that will help it to take its lead epigenetic silencing drug, Tune-401, into clinical testing as a potential ...

There's great news for fans of The Traitors as, with the outcome of this series looking set o go right down to the wire after a huge twist, the final has been extended, meaning the show will begin ...